5-[(5R)-3-amino-5-fluoropiperidin-1-yl]-N-[3-(difluoromethyl)-1-[4-[4-[[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]amino]piperidine-1-carbonyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
C41H48F3N13O4 — CID 172587120
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(5R)-3-amino-5-fluoropiperidin-1-yl]-N-[3-(difluoromethyl)-1-[4-[4-[[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]amino]piperidine-1-carbonyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
5-[(5R)-3-amino-5-fluoropiperidin-1-yl]-N-[3-(difluoromethyl)-1-[4-[4-[[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]amino]piperidine-1-carbonyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 172587120) has the molecular formula C41H48F3N13O4 and a molecular weight of 843.92 g/mol. Its IUPAC name is 5-[(5R)-3-amino-5-fluoropiperidin-1-yl]-N-[3-(difluoromethyl)-1-[4-[4-[[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]amino]piperidine-1-carbonyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | 5-[(5R)-3-amino-5-fluoropiperidin-1-yl]-N-[3-(difluoromethyl)-1-[4-[4-[[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]amino]piperidine-1-carbonyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 172587120 |
| Molecular Formula | C41H48F3N13O4 |
| Molecular Weight | 843.92 g/mol |
| Exact Mass | 843.39 |
| IUPAC Name | 5-[(5R)-3-amino-5-fluoropiperidin-1-yl]-N-[3-(difluoromethyl)-1-[4-[4-[[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]amino]piperidine-1-carbonyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | Cn1nc(C2CCC(=O)NC2=O)c2ccc(NC3CCN(C(=O)C4CCC(n5cc(NC(=O)c6cnn7ccc(N8CC(N)C[C@@H](F)C8)nc67)c(C(F)F)n5)CC4)CC3)cc21 |
| InChI | InChI=1S/C41H48F3N13O4/c1-53-32-17-26(4-7-28(32)35(51-53)29-8-9-34(58)50-39(29)59)47-25-10-13-54(14-11-25)41(61)22-2-5-27(6-3-22)57-21-31(36(52-57)37(43)44)48-40(60)30-18-46-56-15-12-33(49-38(30)56)55-19-23(42)16-24(45)20-55/h4,7,12,15,17-18,21-25,27,29,37,47H,2-3,5-6,8-11,13-14,16,19-20,45H2,1H3,(H,48,60)(H,50,58,59)/t22?,23-,24?,27?,29?/m1/s1 |
| InChIKey | UKHJRESQSMBRIO-ADIVFCEOSA-N |
| XLogP | 4.23 |
| TPSA | 202.70 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 843.92 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172587120 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.